The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy.
 
Leena Gandhi
Consulting or Advisory Role - AstraZeneca; Hengrui Pharmaceutical ; Ignyta; Merck Sharp & Dohme; Roche/Genentech; Syndax
Research Funding - Bristol-Myers Squibb
 
Pasi A. Janne
Stock and Other Ownership Interests - Gatekeeper Pharmaceuticals
Consulting or Advisory Role - Araxes Pharma; ARIAD; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Ignyta; Lilly; LOXO; Merrimack; Mirati Therapeutics; Pfizer; Roche/Genentech
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Lilly; Puma Biotechnology
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a DFCI owned patent on EGFR mutations licensed to Lab Corp. I receive post-marketing royalties from this invention
 
Mateusz Opyrchal
Consulting or Advisory Role - AstraZeneca
Research Funding - Pfizer
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Merck; Takeda
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer
 
Igor I. Rybkin
Consulting or Advisory Role - AstraZeneca
 
Navid Hafez
No Relationships to Disclose
 
Luis E. Raez
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Syndax (Inst)
 
Dmitry Gabrilovich
Consulting or Advisory Role - Janssen Oncology; Peregrine Pharmaceuticals; Syndax
Research Funding - Biothera; Bristol-Myers Squibb; Galera Therapeutics; Janssen Oncology; Syndax
 
Fang Wang
No Relationships to Disclose
 
Peter Ordentlich
Employment - Syndax
Leadership - Syndax
Stock and Other Ownership Interests - Syndax
 
Susan Brouwer
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Serap Sankoh
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Emmett V. Schmidt
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael L. Meyers
Employment - Syndax
Leadership - Syndax
Stock and Other Ownership Interests - Syndax
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb